Sterling Biotech Limited - Company Profile

Q: Who are the current directors of Sterling Biotech Limited?

The current directors of Sterling Biotech Limited are Narayan Tripunithura Mahadeva, Perumal Gandhi, Devesh Choudhari, Alok Kumar Garg, Monisha Prabhu Macedo, Heenaben Devjibhai Pankhania, Vishal Jyotindra Gor, Aftab Mathur, Keyur Anilkumar Parekh, Anil Shantilal Inani, Philip Chacko Mundanilkunnathil, Nikita Ashok Suyani.

It is a pharma public limited company based in Mumbai, Maharashtra, India, established in 1985.

1985 Mumbai, Maharashtra, India Active

Last Updated: December 18, 2025

Access Report

About Sterling Biotech Limited

Sterling Biotech Limited, a active public limited company, was established on 23 March 1985 in Mumbai, Maharashtra, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: L51900MH1985PLC035738. Registered under ROC Roc Mumbai. it is listed on BSE: 512299. It has an authorized capital of ₹2,800.00 Cr and a paid-up capital of ₹643.35 Cr.

Formerly known as Sterling Tea & Indutries Limited, Pluto Exports & Consultants Limited. It upholds a compliant status. In 2024, it reported revenue of ₹476.71 Cr and a net worth of ₹879.42 Cr. Employing 249 professional, Its leadership includes Narayan Tripunithura Mahadeva (Director), Perumal Gandhi (Director), Alok Kumar Garg (Nominee Director). Past directors included Rama Subramaniam Gandhi, Narayan Tripunithura Mahadeva, Perumal Gandhi. It holds ₹703.90 Cr open charges and ₹21,758.44 Cr settled loans. Its latest AGM occurred on 17 September 2025, with the balance sheet filed on 31 March 2025. It is based at Office No. 601, Windfall Building,, Sahar Plaza Complex, Near Hotel Kohinoor, (Andheri East), Mumbai, Maharashtra, 400059.

Company Details

CIN/LLPIN
L51900MH1985PLC035738
Registration Number
035738
Incorporation Date
23 March 1985
Authorized Capital
₹2,800.00 Cr
Paid-Up Capital
₹643.35 Cr
ROC Code
Roc Mumbai
Listing Status
Listed (BSE: 512299)
Company Status
Active

Key Metrics

Authorised Capital ₹ 2,800.00 Cr as on 18-12-2025
Paid Up Capital ₹ 643.35 Cr as on 18-12-2025
Company Age 41 Year, 28 Days
Last Filing with ROC 31 Mar 2025
Open Charges ₹ 703.90 Cr as on 18-12-2025
Satisfied Charges ₹ 21,758.44 Cr as on 18-12-2025
Revenue Growth **** 7.51% (FY 2024)
Profit Growth **** -100.32% (FY 2024)
Ebitda **** 12.73% (FY 2024)
Net Worth -2.14% (FY 2024)
Total Assets **** 0.46% (FY 2024)

Comprehensive Company Insights

Explore comprehensive insights into Sterling Biotech Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Sterling Biotech Limited?

Current Directors

Name	Designation	Appointment Date	Status
Narayan Tripunithura Mahadeva	Director	30 Sep 2023	Current
Perumal Gandhi	Director	17 Nov 2022	Current
Alok Kumar Garg	Nominee Director	29 Aug 2024	Current
Monisha Prabhu Macedo	Nominee Director	24 Mar 2025	Current
Vishal Jyotindra Gor	Nominee Director	29 Aug 2024	Current
Aftab Mathur	Nominee Director	25 Jun 2025	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Director	30 Sep 2023	Past
Pramod Abcsdd	Director	24 Dec 2024	Past
Pramod Abcsdd	Director	10 Oct 2024	Past
Pramod Abcsdd	Director	29 Aug 2024	Past
Pramod Abcsdd	Director	08 Sep 2021	Past
Pramod Abcsdd	Managing Director	17 Nov 2022	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Sterling Biotech.

Sterling Biotech Limited, for the financial year ended 2024, experienced modest growth in revenue, with a 7.51% increase. The company also saw a substantial fall in profitability, with a 100.32% decrease in profit. The company's net worth dipped by a decrease of 2.14%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

7.51%

*******

Revenue from Operations

*******

5.43%

*******

Total Assets

*******

0.46%

*******

Profit or Loss

*******

-100.32%

*******

Net Worth

*******

-2.14%

*******

EBITDA

*******

12.73%

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Sterling Biotech?

In 2024, Sterling Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)

Open Charges

₹7,039,000,000.00

Satisfied Charges

₹217,584,414,000.00

Charges Breakdown by Lending Institutions

Others : 667.00 Cr
State Bank Of India : 22.50 Cr
Hdfc Bank Limited : 14.40 Cr

Latest Charge Details

Date	Lender	Amount	Status
18 Sep 2025	Others	₹95.00 Cr	Open
18 Sep 2025	Others	₹572.00 Cr	Open
28 Nov 2023	State Bank Of India	₹22.50 Cr	Open
19 Oct 2023	Hdfc Bank Limited	₹14.40 Cr	Open
03 Oct 2023	Others	₹24.00 Cr	Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Sterling Biotech?

Sterling Biotech has a workforce of 249 employees as of Mar 27, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Sterling Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sterling Biotech's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Sterling Biotech

Recent Activity within the Organization

Director Appointment

Progress on Nikita Ashok Suyani was appointed as a Company Secretary was appointed as a Company Secretary on 15 Dec 2025 & has been associated with this company since 4 months 6 days . was documented.
15 Dec 2025
Charges

The activity A charge with Others amounted to Rs. 95.00 Cr with Charge ID 101161944 was registered on 18 Sep 2025. was completed.
18 Sep 2025
Charges

A charge with Others amounted to Rs. 572.00 Cr with Charge ID 101161938 was registered on 18 Sep 2025. was recorded as a recent event.
18 Sep 2025
Annual General Meeting

Progress on Sterling Biotech Limited last Annual general meeting of members was held on 17 Sep 2025 as per latest MCA records. was documented.
17 Sep 2025
Director Appointment

The activity Anil Shantilal Inani was appointed as a CFO was appointed as a CFO on 27 Jun 2025 & has been associated with this company since 9 months 24 days . was completed.
27 Jun 2025
Director Appointment

Aftab Mathur was appointed as a Nominee Director was appointed as a Nominee Director on 25 Jun 2025 & has been associated with this company since 9 months 26 days . was recorded as a recent event.
25 Jun 2025

Explore recent activity and updates - View Recent Activity